Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.15M Buy
76,686
+39,301
+105% +$1.05M 0.03% 624
2025
Q4
$931K Sell
37,385
-60,945
-62% -$1.54M 0.01% 997
2025
Q3
$2.51M Buy
+98,330
New +$2.43M 0.03% 658
2025
Q2
Sell
-1,260,938
Closed -$32M 2067
2025
Q1
$32M Buy
1,260,938
+949,651
+305% +$24.8M 0.44% 43
2024
Q4
$8.26M Sell
311,287
-477,574
-61% -$13M 0.17% 153
2024
Q3
$22.8M Buy
788,861
+584,670
+286% +$17.1M 0.47% 30
2024
Q2
$5.71M Sell
204,191
-138,154
-40% -$3.8M 0.11% 200
2024
Q1
$9.5M Buy
342,345
+186,424
+120% +$5.17M 0.26% 47
2023
Q4
$4.49M Buy
155,921
+135,137
+650% +$4.09M 0.14% 133
2023
Q3
$689K Sell
20,784
-16,594
-44% -$587K 0.03% 846
2023
Q2
$1.37M Buy
37,378
+12,678
+51% +$493K 0.05% 537
2023
Q1
$1.01M Buy
24,700
+19,644
+389% +$848K 0.04% 593
2022
Q4
$259K Buy
+5,056
New +$242K 0.01% 1127
2022
Q2
Sell
-24,009
Closed -$1.24M 1930
2022
Q1
$1.24M Buy
+24,009
New +$1.25M 0.05% 445
2021
Q4
Sell
-44,910
Closed -$1.93M 1636
2021
Q3
$1.93M Buy
+44,910
New +$1.99M 0.14% 159
2021
Q2
Sell
-14,255
Closed -$516K 1328
2021
Q1
$516K Buy
+14,255
New +$506K 0.05% 393

Other funds holding PFE

Jump Financial's PFE Position: Q1 2026 in Review

Jump Financial increased its Pfizer (PFE) stake by 105% in Q1 2026, buying an estimated $1.05M and bringing the position to 76,686 shares worth $2.15M. The position accounts for 0.03% of the portfolio, ranked #624.

Jump Financial first reported a position in PFE in Q1 2021 and has held it in 16 quarters since. The position peaked at $32M in Q1 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Jump Financial held 76,686 shares of Pfizer worth $2.15M as of Q1 2026.
  • Jump Financial bought 39,301 Pfizer shares in Q1 2026, an estimated $1.05M.
  • Pfizer made up 0.03% of Jump Financial's portfolio in Q1 2026, its #624 holding.
  • Jump Financial first reported a position in Pfizer in Q1 2021 and has held it in 16 quarters since.
  • Jump Financial's Pfizer position peaked at $32M in Q1 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.